Both soluble Fms-like tyrosine kinase 1 (sFlt-1), an endogenous inhibitor of vascular endothelial growth factor
and placental growth factor signalling, and soluble endoglin (sEnga circulating co-receptor of transforming growth factor-β, have been shown to be increased in the serum of pre-eclamptic women, when compared with normal pregnancy.